E
AN2 Therapeutics, Inc. ANTX
$1.07 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Total Cash And Short-Term Investments -33.72% -39.82% -41.28% -22.07% -24.55%
Total Receivables -40.00% 33.33% -- -78.57% --
Inventory -- -- -- -- --
Prepaid Expenses -54.18% 61.97% 4.56% 29.36% 25.94%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -34.47% -37.15% -40.20% -21.94% -22.72%

Total Current Assets -34.47% -37.15% -40.20% -21.94% -22.72%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -70.85% -22.91% --
Total Assets -31.17% -30.10% -32.92% -33.63% -36.49%

Total Accounts Payable 30.10% 12.10% 26.30% 23.95% -64.92%
Total Accrued Expenses -36.72% -45.95% -42.19% -42.70% -21.76%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -85.65% 28.26% 14.95% 18.41% 30.64%
Total Other Current Liabilities -85.65% 28.26% 14.95% 18.41% 30.64%
Total Current Liabilities -31.54% -31.05% -24.84% -27.10% -32.50%

Total Current Liabilities -31.54% -31.05% -24.84% -27.10% -32.50%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -31.54% -31.05% -24.84% -27.10% -32.50%

Common Stock & APIC 2.36% 2.75% 2.87% 3.12% 3.31%
Retained Earnings -17.14% -20.15% -26.51% -33.23% -44.12%
Treasury Stock & Other -42.86% 192.59% -9.43% -88.73% 191.80%
Total Common Equity -31.13% -30.01% -33.70% -34.36% -36.91%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -31.13% -30.01% -33.70% -34.36% -36.91%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -31.13% -30.01% -33.70% -34.36% -36.91%